Skip to main content
Maag-, Darm- en Leverziekten · AZ Delta

Liver Diseases

Study team

051 23 75 34ctc.hepato@azdelta.be

Studies

3 studies

  • ADRENALIN-GAAD scoreLiver diseaseOpen for participation

    The Value of the GAAD Score in the Early Detection of Liver Cancer

  • Enlighten – New Treatment for MASH Cirrhosis (Advanced Liver Disease)MASH Cirrhosis (Compensated Cirrhosis Due to MASH)Open for participation

    A Phase III study to evaluate the efficacy and safety of pegozafermine in subjects with compensated cirrhosis resulting from metabolic dysfunction-associated steatohepatitis (MASH).

  • SYNERGY-OUTCOMES - Tirzepatide and Retatrutide in MASLDHepatoOpen for participation

    A master protocol for a randomized, controlled clinical trial involving multiple pharmacological agents in adult participants with metabolic dysfunction-associated steatotic liver disease who are at increased risk of developing severe liver problems